Dr. Steven Allday, world-renowned equine lameness veterinarian, has cared for the world’s top thoroughbred racing athletes including Kentucky Derby winners, Breeder’s Cup Winners and more. A complete visionary in the horse health arena, Dr. Allday worked tirelessly to create a joint formula that was safe, non-invasive, and cost effective for his racetrack clientele.  Halstrum, LLC was born in 2004 with the idea that there was a better way to care for horses’ joints and quickly LubriSynHA became one of the best-selling and is the most effective joint supplements throughout all equine disciplines. 

Over the years we have expanded our product lines to include pets, livestock, and even people. Our patented liquid high molecular weight hyaluronic acid has fit perfectly into the lives and budgets of our loyal customers.  In 2015, we launched LubriSynHA Plus fortified with MSM which has allowed us to provide our customers with a faster, more effective product that eliminated the need for multiple supplements.

Our company’s passion for taking care of animals has also allowed us to grow to include nutritional and optimum health supplements that are unequaled in the animal health industry. Re-Borne Whole Bovine Colostrum is colostrum sourced from Grade A Dairies that is processed and sterilized to keep in its original liquid state and avoid degradation through a heating or pasteurization process. The valuable constituents such as proteins, antibodies, and other nutrients provide a complete nutritional supplement for pets, horses, and livestock alike. 

The newest addition to the LubriSynHA Family of Products is our LubriSynHA Topical: Advanced Wound Gel with Hyaluronic Acid. We took the vital properties of hyaluronic acid and its ability to assist in tissue regeneration and paired it with chitosan, a natural coagulant, and created a topical wound gel that helps heal wounds quicker than any other wound care product on the market. 

Mission Statement;

Halstrum, LLC is a team of experts who pioneer and develop safe, all-natural products that dramatically improve the quality of life for all humans and animals alike.

We have prided ourselves on this for over the past 15 years and we look forward to serving our loyal customers well into the future. We will always continue to strive in developing the most progressive supplements in the marketplace.

Thank you from everyone at Halstrum.



Bucci, LR, and AA Turpin. “Will the real hyaluronan please stand up?” J of Appl Nutr 54, no. 1 (2004): 10-33.
Cantor, JO, and PP Nadkarni. “Hyaluronan: the Jekyll and Hyde molecule.” Inflamm Allergy Drug Targets 5, no. 4 (Dec 2006): 257-260.
Gotoh, S, et al. “Effects of the molecular weight of hyaluronic acid and its action mechanisms on experimental joint pain in rats.” Ann Rheum Dis 52, no. 11 (Nov 1993): 817-822.
Ishimaru, JI, N Ogi, S Mizuno, and AN Goss. “Quantitation of chondroitin-sulfates, disaccharides and hyaluronan in normal, early and advanced osteoarthritic sheep temporomandibular joints.” Osteoarthritis Cartilage 9, no. 4 (May 2001): 365-370.
Moreland, LW. “Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action.” Arthritis Res Ther 5, no. 2 (2003): 54-67.
Nakamura, K, et al. “High, but not low, molecular weight hyaluronan prevents T-cell-mediated liver injury by reducing proinflammatory cytokines in mice.” J Gastroenterol 39, no. 4 (2004): 346-354.
Novartis. Clinical Studies. 2005. http://www.adequancanine.us/vet/en/vet_clinicalStudies.shtml (accessed Feb 22, 2007).
NutraMax Laboratories, Inc. 2005. http://www.nutramaxlabs.com/Brochures/Cosequin Dog Brochure.pdf (accessed Feb 22, 2007).
Ohkawara, Y, G Tamura, T Iwasaki, A Tanaka, T Kikuchi, and K Shirato. “Activation and transforming growth factor-beta production in eosinophils by hyaluronan.” Am J Respir Cell Mol Biol 23, no. 4 (Oct 2000): 444-451.
Schauss, AG, LG Balogh, AG Polyak, RG Kiraly, and i GG Janok. “Absorption, distribution and excretion of 99mtechnetium labeled hyaluronan after single oral doses in rats and beagle dogs.” FASEB j 18, no. 4 (2004): A150-151.
Takahashi, T, et al. “A decreae in the molecular weight of hyaluronic acid in synovial fluid from patients with temporomandibular disorders.” J Oral Pathol Med 33, no. 4 (Apr 2004): 224-229.
Yeung, RW, RL Chow, Samman N, and K Chiu. “Short-term therapeutic outcome of intra-articular high molecular weight hyaluronic acid injection for non-reducing disc displacement of the temporomandibular joint.” Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102, no. 4 (Oct 2006): 453-461.